Literature DB >> 26611260

Smartphone speech-to-text applications for communication with profoundly deaf patients.

F C Lyall1, P J Clamp2, D Hajioff2.   

Abstract

OBJECTIVE: Visual communication aids, such as handwriting or typing, are often used to communicate with deaf patients in the clinic. This study aimed to establish the feasibility of communicating through smartphone speech recognition software compared with writing or typing.
METHOD: Thirty doctors and medical students were timed writing, typing and dictating a standard set of six sentences appropriate for a post-operative consultation, and the results were assessed for accuracy and legibility.
RESULTS: The mean time for smartphone dictation (17.8 seconds, 95 per cent confidence interval = 17.0-18.7) was significantly faster than writing (59.2 seconds, 95 per cent confidence interval = 56.6-61.7) or typing (44 seconds, 95 per cent confidence interval = 41.0-47.1) (p < 0.001). Speech recognition was slightly less accurate, but accuracy increased with time spent dictating.
CONCLUSION: Smartphone dictation is a feasible alternative to typing and handwriting. Slow speech may improve accuracy. Early clinical experience has been promising.

Entities:  

Keywords:  Cell Phones; Cochlear Implantation; Communication Aids for Disabled; Communication Methods; Persons With Hearing Impairments; Postoperative Care; Speech Recognition Software; Total; Writing

Mesh:

Year:  2015        PMID: 26611260     DOI: 10.1017/S0022215115003151

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  2 in total

1.  Intraoral voice recording-towards a new smartphone-based method for vocal rehabilitation.

Authors:  T Schuldt; B Kramp; A Ovari; D Timmermann; S Dommerich; R Mlynski; P Ottl
Journal:  HNO       Date:  2018-07       Impact factor: 1.284

2.  [Intraoral voice recording-towards a new smartphone-based method for vocal rehabilitation. German version].

Authors:  T Schuldt; B Kramp; A Ovari; D Timmermann; S Dommerich; R Mlynski; P Ottl
Journal:  HNO       Date:  2018-10       Impact factor: 1.284

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.